Accès gratuit
Numéro
Med Sci (Paris)
Volume 27, Numéro 12, Décembre 2011
Page(s) 1078 - 1080
Section Nouvelles
DOI http://dx.doi.org/10.1051/medsci/20112712014
Publié en ligne 23 décembre 2011
  1. Crystal H, Dickson D, Fuld P, et al. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer’s disease. Neurology 1988 ; 38 : 1682–1687. [CrossRef] [PubMed]
  2. Jack CR Jr, Lowe VJ, Senjem ML, et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer’s disease and amnestic mild cognitive impairment. Brain 2008 ; 131 : 665–680. [CrossRef] [PubMed]
  3. Storandt M, Mintun MA, Head D, Morris JC. Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition. Arch Neurol 2009 ; 66 : 1476–1481. [CrossRef] [PubMed]
  4. Dickerson BC, Bakkour A, Salat DH, et al. The cortical signature of Alzheimer’s disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex 2009 ; 19 : 497–510. [CrossRef] [PubMed]
  5. Bourgeat P, Chételat G, Villemagne VL, et al. Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia. Neurology 2010 ; 74 : 121–127. [CrossRef] [PubMed]
  6. Chételat G, Villemagne VL, Bourgeat P, et al. Relationship between atrophy and β-amyloid deposition in Alzheimer’s disease. Ann Neurol 2010 ; 67 : 317–324. [PubMed]
  7. Chételat G, Villemagne VL, Pike KE, et al. Larger temporal volume in asymptomatic elderly with high versus low beta-amyloid deposition. Brain 2010 ; 133 : 3349–3358. [CrossRef] [PubMed]
  8. Chételat G, Villemagne VL, Bourgeat P, et al. Relationship between atrophy and β-amyloid deposition in Alzheimer’s disease. Ann Neurol 2010 ; 67 : 317–324. [PubMed]